Cargando…

Measles Vaccines Designed for Enhanced CD8(+) T Cell Activation

Priming and activation of CD8(+) T cell responses is crucial to achieve anti-viral and anti-tumor immunity. Live attenuated measles vaccine strains have been used successfully for immunization for decades and are currently investigated in trials of oncolytic virotherapy. The available reverse geneti...

Descripción completa

Detalles Bibliográficos
Autores principales:	Busch, Elena, Kubon, Kristina D., Mayer, Johanna K. M., Pidelaserra-Martí, Gemma, Albert, Jessica, Hoyler, Birgit, Heidbuechel, Johannes P. W., Stephenson, Kyle B., Lichty, Brian D., Osen, Wolfram, Eichmüller, Stefan B., Jäger, Dirk, Ungerechts, Guy, Engeland, Christine E.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077255/ https://www.ncbi.nlm.nih.gov/pubmed/32098134 http://dx.doi.org/10.3390/v12020242

Ejemplares similares

Oncolytic measles vaccines encoding PD-1 and PD-L1 checkpoint blocking antibodies to increase tumor-specific T cell memory
por: Veinalde, Rūta, et al.
Publicado: (2021)

Measles Virus as an Oncolytic Immunotherapy
por: Engeland, Christine E., et al.
Publicado: (2021)

Immunological Effects and Viral Gene Expression Determine the Efficacy of Oncolytic Measles Vaccines Encoding IL-12 or IL-15 Agonists
por: Backhaus, Paul S., et al.
Publicado: (2019)

Enhanced Control of Oncolytic Measles Virus Using MicroRNA Target Sites
por: Leber, Mathias Felix, et al.
Publicado: (2018)

Oncolytic Measles Virus Encoding MicroRNA for Targeted RNA Interference †
por: Anker, Sophie C., et al.
Publicado: (2023)

Virotherapy combined with anti-PD-1 transiently reshapes the tumor immune environment and induces anti-tumor immunity in a preclinical PDAC model
por: Veinalde, Rūta, et al.
Publicado: (2023)

Controlling the Immune Suppressor: Transcription Factors and MicroRNAs Regulating CD73/NT5E
por: Kordaß, Theresa, et al.
Publicado: (2018)

MicroRNA-sensitive oncolytic measles virus for chemovirotherapy of pancreatic cancer
por: Singh, Hans Martin, et al.
Publicado: (2021)

SOX9 is a target of miR-134-3p and miR-224-3p in breast cancer cell lines
por: Chao, Tsu-Yang, et al.
Publicado: (2022)

Novel microRNAs modulating ecto-5′-nucleotidase expression
por: Kordaß, Theresa, et al.
Publicado: (2023)

Cognate Interaction With CD4(+) T Cells Instructs Tumor-Associated Macrophages to Acquire M1-Like Phenotype
por: Eisel, David, et al.
Publicado: (2019)

Oncolytic viruses encoding bispecific T cell engagers: a blueprint for emerging immunovirotherapies
por: Heidbuechel, Johannes P. W., et al.
Publicado: (2021)

Engineering and combining oncolytic measles virus for cancer therapy
por: Leber, Mathias F., et al.
Publicado: (2020)

miR-193b and miR-30c-1(*) inhibit, whereas miR-576-5p enhances melanoma cell invasion in vitro
por: Kordaß, Theresa, et al.
Publicado: (2018)

Correction: Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system
por: Das, Krishna, et al.
Publicado: (2018)

Generation of murine tumor cell lines deficient in MHC molecule surface expression using the CRISPR/Cas9 system
por: Das, Krishna, et al.
Publicado: (2017)

Reprogramming of macrophages employing gene regulatory and metabolic network models
por: Hörhold, Franziska, et al.
Publicado: (2020)

Tumor-Specific Delivery of Immune Checkpoint Inhibitors by Engineered AAV Vectors
por: Reul, Johanna, et al.
Publicado: (2019)

A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice
por: Das, Krishna, et al.
Publicado: (2019)

MiR-192, miR-200c and miR-17 are fibroblast-mediated inhibitors of colorectal cancer invasion
por: Ast, Volker, et al.
Publicado: (2018)

Radiation-induced alterations in immunogenicity of a murine pancreatic ductal adenocarcinoma cell line
por: Schröter, Philipp, et al.
Publicado: (2020)

Replication-Competent Foamy Virus Vaccine Vectors as Novel Epitope Scaffolds for Immunotherapy
por: Lei, Janet, et al.
Publicado: (2015)

MicroRNAs affecting the susceptibility of melanoma cells to CD8(+) T cell‐mediated cytolysis
por: Pane, Antonino A., et al.
Publicado: (2023)

Safety study supports clinical development of immunotherapeutic oncolytic measles vaccine
por: Engeland, Christine E.
Publicado: (2022)

Screening of Human Tumor Antigens for CD4(+) T Cell Epitopes by Combination of HLA-Transgenic Mice, Recombinant Adenovirus and Antigen Peptide Libraries
por: Osen, Wolfram, et al.
Publicado: (2010)

Photon versus carbon ion irradiation: immunomodulatory effects exerted on murine tumor cell lines
por: Hartmann, Laura, et al.
Publicado: (2020)

How the EU animal welfare legislation can tackle AMR – a One Health perspective
por: Pegger, T, et al.
Publicado: (2023)

A comparative analysis of measles virus RNA by oligonucleotide fingerprinting
por: Stephenson, J. R., et al.
Publicado: (1982)

Measles or Not Measles? That Is the Question!
por: Ibraheim, Marina Kristy, et al.
Publicado: (2020)

STUDIES ON MEASLES : I. SUSCEPTIBILITY OF MONKEYS TO THE VIRUS OF MEASLES.
por: Blake, Francis G., et al.
Publicado: (1921)

An Atypical Case of Measles
por: Rai, B. B.
Publicado: (1946)

Measles in Horses
por: Lee, Daniel D.
Publicado: (1891)

Fighting Cancer with Mathematics and Viruses
por: Santiago, Daniel N., et al.
Publicado: (2017)

STUDIES ON MEASLES : III. ACQUIRED IMMUNITY FOLLOWING EXPERIMENTAL MEASLES.
por: Blake, Francis G., et al.
Publicado: (1921)

Measles Outbreak in South Africa: Epidemiology of Laboratory-Confirmed Measles Cases and Assessment of Intervention, 2009–2011
por: Ntshoe, Genevie M., et al.
Publicado: (2013)

Reported measles cases, measles-related deaths and measles vaccination coverage in Myanmar from 2014 to 2018
por: Thar, Aye Mya Chan, et al.
Publicado: (2020)

Epidemic Measles in Assam
por: Manson, D.
Publicado: (1935)

A vector-encoded bispecific killer engager to harness virus-activated NK cells as anti-tumor effectors
por: Floerchinger, Alessia, et al.
Publicado: (2023)

The Prevention and Attenuation of Measles
por: Allison, V. D.
Publicado: (1933)

Measles Vaccination in Presence of Measles Antibody May Enhance Child Survival
por: Benn, Christine S., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_llb10ttb43hn358o003jaf7jkc